These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15333681)

  • 61. Clinical applications of plasma Epstein-Barr virus DNA analysis and protocols for the quantitative analysis of the size of circulating Epstein-Barr virus DNA.
    Chan KC; Lo YM
    Methods Mol Biol; 2006; 336():111-21. PubMed ID: 16916257
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a non-endemic area.
    Alfieri S; Iacovelli NA; Marceglia S; Lasorsa I; Resteghini C; Taverna F; Mazzocchi A; Orlandi E; Guzzo M; Bianchi R; Fanti D; Pala L; Racca S; Dvir R; Quattrone P; Gloghini A; Volpi CC; Granata R; Bergamini C; Locati L; Licitra L; Bossi P
    Oncotarget; 2017 Jul; 8(29):47780-47789. PubMed ID: 28562354
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epstein-Barr virus strain characterisation in South African patients with nasopharyngeal carcinomas.
    Janse van Rensburg E; van Heerden WF; Robson BA; Swart TJ; Engelbrecht S
    Anticancer Res; 2000; 20(3B):1953-7. PubMed ID: 10928133
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma.
    Tong JH; Tsang RK; Lo KW; Woo JK; Kwong J; Chan MW; Chang AR; van Hasselt CA; Huang DP; To KF
    Clin Cancer Res; 2002 Aug; 8(8):2612-9. PubMed ID: 12171892
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Epstein-Barr virus DNA in serum/plasma as a tumor marker for nasopharyngeal cancer.
    Shotelersuk K; Khorprasert C; Sakdikul S; Pornthanakasem W; Voravud N; Mutirangura A
    Clin Cancer Res; 2000 Mar; 6(3):1046-51. PubMed ID: 10741733
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Latency of Epstein-Barr virus and its relationship to nasopharyngeal carcinomas].
    You S; Yao K; Cao Y
    Zhonghua Zhong Liu Za Zhi; 1996 Jan; 18(1):23-6. PubMed ID: 8732106
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quantitative plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients.
    Pratesi C; Bortolin MT; D'Andrea M; Vaccher E; Barzan L; Bidoli E; Tedeschi R; Zanussi S; de Paoli P
    J Clin Virol; 2003 Oct; 28(2):155-64. PubMed ID: 12957185
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Polymorphism analysis of Epstein-Barr virus isolates of nasopharyngeal carcinoma biopsies from Tunisian patients.
    Ayadi W; Feki L; Khabir A; Boudawara T; Ghorbel A; Charfeddine I; Daoud J; Frikha M; Hammami A; Karray-Hakim H
    Virus Genes; 2007 Apr; 34(2):137-45. PubMed ID: 17216568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epstein-Barr virus DNA and epithelial markers in nasopharyngeal carcinoma.
    Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
    Med Microbiol Immunol; 2003 Aug; 192(3):141-4. PubMed ID: 12920589
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Herbal medicine use, Epstein-Barr virus, and risk of nasopharyngeal carcinoma.
    Hildesheim A; West S; DeVeyra E; De Guzman MF; Jurado A; Jones C; Imai J; Hinuma Y
    Cancer Res; 1992 Jun; 52(11):3048-51. PubMed ID: 1317256
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals.
    Shu CH; Tu TY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The value of polymerase chain reaction on Epstein-Barr virus subtypes in the differentiation of benign and malignant nasopharyngeal biopsies].
    Sun N; Chen X
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):213-5. PubMed ID: 8745459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan.
    Yang X; Goldstein AM; Chen CJ; Rabkin CS; Chen JY; Cheng YJ; Hsu WL; Sun B; Diehl SR; Liu MY; Walters M; Shao W; Ortiz-Conde BA; Whitby D; Elmore SH; Gulley ML; Hildesheim A
    Int J Cancer; 2006 Feb; 118(3):780-4. PubMed ID: 16106400
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sequencing-based counting and size profiling of plasma Epstein-Barr virus DNA enhance population screening of nasopharyngeal carcinoma.
    Lam WKJ; Jiang P; Chan KCA; Cheng SH; Zhang H; Peng W; Tse OYO; Tong YK; Gai W; Zee BCY; Ma BBY; Hui EP; Chan ATC; Woo JKS; Chiu RWK; Lo YMD
    Proc Natl Acad Sci U S A; 2018 May; 115(22):E5115-E5124. PubMed ID: 29760067
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The sequence analysis of Epstein-Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified?
    Banko AV; Lazarevic IB; Karalic DZ; Djukic VB; Cupic MD; Stevanovic G; Jovanovic TP
    Med Microbiol Immunol; 2019 Feb; 208(1):81-88. PubMed ID: 30203133
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Response of nasopharyngeal carcinoma cells to Epstein-Barr virus infection in vitro.
    Lin CT; Kao HJ; Lin JL; Chan WY; Wu HC; Liang ST
    Lab Invest; 2000 Aug; 80(8):1149-60. PubMed ID: 10950106
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Variations of Epstein-Barr virus nuclear antigen 1 gene in gastric carcinomas and nasopharyngeal carcinomas from Northern China.
    Wang Y; Liu X; Xing X; Cui Y; Zhao C; Luo B
    Virus Res; 2010 Feb; 147(2):258-64. PubMed ID: 19941915
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma.
    King AD; Woo JKS; Ai QY; Chan JSM; Lam WKJ; Tse IOL; Bhatia KS; Zee BCY; Hui EP; Ma BBY; Chiu RWK; van Hasselt AC; Chan ATC; Lo YMD; Chan KCA
    Ann Oncol; 2019 Jun; 30(6):977-982. PubMed ID: 30912815
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.
    Lam WKJ; Chan KCA; Lo YMD
    J Pathol; 2019 Apr; 247(5):641-649. PubMed ID: 30714167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.